Hemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Hemophilus influenzae, Staphylococcus aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis

Abstract

References

Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families

Current concepts in genetics. Cystic fibrosis

Polyagglutinating and non-typable strains of Pseudomonas aeruginosa in cystic fibrosis

Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis.

Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients.

The role of immune complexes in the pathogenesis of bacterial infections

Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis

Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology.

Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase.

Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection

An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre

Transfer of a chromosomal locus responsible for mucoid colony morphology in Pseudomonas aeruginosa isolated from cystic fibrosis patients to P. aeruginosa PAO

Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection

Pulmonary infection in cystic fibrosis

Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis

Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?

Selective modulation of the CD4 molecular complex by Pseudomonas aeruginosa alkaline protease and elastase

Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.

Virulence factors of Pseudomonas aeruginosa

Characterization of the Pseudomonas aeruginosa alginate (alg) gene region II

Immunologic aspects of cystic fibrosis

Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells.

Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients

The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis

Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology

A comparative study of amoxycillin and pivampicillin in persistent Haemophilus influenzae infection of the lower respiratory tract in children with chronic lung disease

Pseudomonas species contamination of cystic fibrosis patients' home inhalation equipment

Staphylococcus aureus: biology, mechanisms of virulence, epidemiology

Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients

Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes

Distribution of biotypes of Haemophilus influenzae and H parainfluenzae in patients with cystic fibrosis

Oral colonization and susceptibility testing of Pseudomonas aeruginosa oral isolates from cystic fibrosis patients

Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.

Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa.

Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition.

Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome

Bacterial infection in cystic fibrosis

Does pseudomonas cross-infection occur between cystic-fibrosis patients

Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic

Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum

Interaction of Pseudomonas aeruginosa alkaline protease and elastase with human polymorphonuclear leukocytes in vitro.

Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence.

Antibiotic treatment of Haemophilus influenzae and Haemophilus parainfluenzae infections in patients with cystic fibrosis

Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis

The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis

Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.

Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.

Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay.

Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa

Citations

Comparison of serum amyloid A and C-reactive protein as indicators of lung inflammation in corticosteroid treated and non-corticosteroid treated cystic fibrosis patients

Prevention and treatment of infections in cystic fibrosis

Epidemiology of Staphylococcus aureus in patients with cystic fibrosis

Sequential biosynthesis of sulfated and/or sialylated Lewis x determinants by transferases of the human bronchial mucosa

Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells

Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis

Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.

Structure of the O-specific galactan from the lipopolysaccharide of the reference strain for Serratia marcescens serogroup O24.

Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia

Review: Staphylococcus aureus and MRSA in cystic fibrosis

Pseudomonas cepacia in lung transplant recipients with cystic fibrosis

Characterization of an N-acetylglucosamine-6-O-sulfotransferase from human respiratory mucosa active on mucin carbohydrate chains.

Lung inflammation and disease: A perspective on microbial homeostasis and metabolism

Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.

Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre

Cell therapy for cystic fibrosis

Staphylococcus aureus in patients with cystic fibrosis: an epidemiological analysis using a combination of traditional and molecular methods

Characterization of a sulfotransferase from human airways responsible for the 3-O-sulfation of terminal galactose in N-acetyllactosamine-containing mucin carbohydrate chains.

Structures of the O-specific polymers from the lipopolysaccharides of the reference strains for Pseudomonas cepacia serogroups O3 and O5.

Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro.

Recurrent infections and chronic colonization by an Escherichia coli clone in the respiratory tract of a patient with severe cystic bronchiectasis

Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Related Concepts

Related Feeds

CRISPR & Staphylococcus

Related Papers